MedPath

A STUDY OF FEASIBILITY OF ENTONOX AS AN ANALGESIC IN THE EMERGENCY DEPARTMENT

Phase 1
Registration Number
CTRI/2009/091/000825
Lead Sponsor
Self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Any person who presents acute pain or / and planed for painful procedure in the emergency room between the age group of 15 years and above

Exclusion Criteria

1. Chest Injuries (i.e. suspected pneumo or haemothorax unless a chest drain is in situ)
2. Gross abdominal distension or suspected bowel obstruction
3. Head Injuries (severe with impaired consciousness)
4. Maxillofacial injuries
5. Intoxication with alcohol or drugs (those patients unable to comply with instruction)
6. Air embolism
7. Decompression sickness.
8. Anyone who has been diving in the previous 24hours
9. Unconscious patients
10. Psychiatric patients those are violently disturbed

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study showed that for study group (Entonox) the overall mean for pre-treatment Visual analogue scale (VAS) score were 6.5 and the overall mean for post-treatment VAS score was 2; for control group (fentanyl) overall mean for pre-treatment VAS score was 7.0 and the overall mean for post-treatment VAS score was 1.0.<br>Timepoint: The mean time taken to initiate the therapy was 45 seconds in study group where as control group took 4.8 minutes.<br> No patients had hemodynamic instability or respiratory arrest with entonox where as 17.5% of patients had hemodynamic instability and 7.5% of the patients had respiratory arrest and requiring definitive airway placement and temporary ventilatory support for 30 -45 minutes in fentanyl group. <br>Post procedure observation period in emergency room was 20 minutes in entonox group where as it was 2 hours for fentanyl group.<br>
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath